According to the bank document, the project is a loan of up to CNY130.0 million (or its equivalent in US dollars) to Jointown Pharmaceutical Group Co., Ltd. The proceeds of the loan will be used to fund the working capital needs of Jointown during the ongoing coronavirus disease 2019 (COVID-19) epidemic. The project will enhance emergency storage and distribution facilities for medical supplies, increase the provision of emergency medical supplies including drugs and devices, and sustain the resilience of critical health emergency response workers.
The project objective is to strengthen the capabilities regarding emergency medical assistance, and disease prevention and control.
|Private Actor 1||Private Actor 1 Role||Private Actor 1 Sector||Relation||Private Actor 2||Private Actor 2 Role||Private Actor 2 Sector|
|-||-||-||-||Jointown Pharmaceutical Group Co., Ltd.||Client||-|
*There is no further information being disclosed at this stage of the project*
ACCOUNTABILITY MECHANISM OF ADB
The Accountability Mechanism is an independent complaint mechanism and fact-finding body for people who believe they are likely to be, or have been, adversely affected by an Asian Development Bank-financed project. If you submit a complaint to the Accountability Mechanism, they may investigate to assess whether the Asian Development Bank is following its own policies and procedures for preventing harm to people or the environment. You can learn more about the Accountability Mechanism and how to file a complaint at: http://www.adb.org/site/accountability-mechanism/main